| 标题 |
[求助补充材料]
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Marc Ferrante; Geert D’Haens; Vipul Jairath; Silvio Danese; Minhu Chen; et al 出版日期:2024-11-21 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)